Sialylation levels of anti-proteinase 3 antibodies are associated with the activity of granulomatosis with polyangiitis (Wegener's)
Arthritis & Rheumatism2011Vol. 63(7), pp. 2105–2115
Citations Over TimeTop 10% of 2011 papers
Cécile Espy, Willy Morelle, Niloufar Kavian, P. Grange, Claire Goulvestre, Vivian Viallon, Christiane Chéreau, Christian Pagnoux, Jean‐Claude Michalski, Loı̈c Guillevin, Bernard Weill, Frédéric Batteux, Philippe Guilpain
Abstract
The sialylation level of anti-PR3 antibodies contributes to the clinical activity of GPA, by modulating the oxidative burst of neutrophils induced by these autoantibodies.
Related Papers
- → Evaluation and validation of biomarkers in granulomatosis with polyangiitis and microscopic polyangiitis(2015)66 cited
- → Clinical Characteristics of an Internet-Based Cohort of Patient-Reported Diagnosis of Granulomatosis With Polyangiitis and Microscopic Polyangiitis: Observational Study(2020)17 cited
- → Treatment of Granulomatosis with Polyangiitis and Microscopic Polyangiitis(2020)8 cited
- → Maintaining remission in patients with granulomatosis with polyangiitis or microscopic polyangiitis: the role of ANCA(2017)9 cited
- → Evidence-based therapy for the ANCA-associated vasculitides: what do the trials show so far?(2014)